Dr Reddys Laboratories Share Price Today - Live Blog for August 19, 2025

Dr Reddys Laboratories Ltd's shares experienced a 0.18% uptick, and they are currently valued at ₹1,246.40, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd shares experienced a -0.03% reduction, with the current market price at ₹1,244.00. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd experienced a substantial 0.03% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,244.00, making it an appealing option for investors.

Dr Reddys Laboratories Ltd observed a -0.15% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,243.60. The stock has a PE ratio of 18.5700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.06%, reaching the current market price of ₹1,245.45. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's stock price surged by 0.02%, reaching the current market value of ₹1,245.85 per share. This surge is a testament to the stock's recent performance.

With a -0.10% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,245.70. The stock is currently trading at a PE of 18.5700, while the industry PE is 34.8520, prompting investors to assess its value proposition.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.02% drop, and it's now trading at ₹1,247.20 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.18% increase and currently trading at ₹1,249.30 per share. This upward trajectory is turning heads in the market.

Dr Reddys Laboratories Ltd stock price decreased by -0.53%, with the current market value at ₹1,247.95 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.15%, reaching a current market price of ₹1,258.15. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd's share price has fallen by -0.15%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,258.15, and market participants are assessing the implications. The stock has a PE ratio of 18.5700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.03%, reaching the current market price of ₹1,261.25. This development underscores the stock's growing popularity.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.03% increase and currently trading at ₹1,261.25 per share. This upward trajectory is turning heads in the market.

Dr Reddys Laboratories Ltd experienced a -0.02% downturn in its share price, and it's currently trading at ₹1,259.70. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd shares experienced a -0.06% reduction, with the current market price at ₹1,260.05. Investors are carefully considering their positions and seeking insights into the stock's future performance.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.04% increase and currently trading at ₹1,260.75 per share. This upward trajectory is turning heads in the market.

Dr Reddys Laboratories Ltd's share price rallied by 0.12%, reaching the current market price of ₹1,261.15. This surge is indicative of the stock's recent positive performance.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.21% gain, with the share price now at ₹1,259.00. Notably, the stock's PE ratio stands at 18.5700, and its Return on Equity (ROE) is 16.8559%.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.03%, reaching the current market price of ₹1,256.40. This development underscores the stock's growing popularity.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.15%, signalling a challenging period. Currently trading at ₹1,257.85, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.12%, reaching the current market price of ₹1,259.75. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.20%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,258.00 per share.

With a -0.18% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,254.25. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.5700, while the industry PE is 34.8520.

Dr Reddys Laboratories Ltd's share price rallied by 0.19%, reaching the current market price of ₹1,256.40. This surge is indicative of the stock's recent positive performance.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.06% drop, and it's now trading at ₹1,254.70 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 4.56% increase and currently trading at ₹1,254.70 per share. This upward trajectory is turning heads in the market.